Found 8 matching trials
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
PHASE2Dementia with Lewy Bodies (DLB) is an alphasynucleinopathy and the second m...
Location
MedStar Georgetown University Hospital
Nilotinib in Parkinson's Disease
PHASE2This study will assess the safety and tolerability of daily oral administra...
Location
University of Alabama at Birmingham
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease
PHASE2Parkinson's disease (PD) is the second most common neurodegenerative disord...
Location
MedStar Georgetown University Hospital
Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)
PHASE2The purpose of this trial was to establish the safety, tolerability and PK ...
Location
Novartis Investigative Site
Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease
PHASE3This study will investigate the safety and efficacy of a Tyrosine Kinase In...
Location
Multiple Locations
Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease
PHASE2The investigators hypothesize that Nilotinib will be safe in individuals wi...
Location
Georgetown University Medical Center
Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients
NAThe goal of this clinical research study is to learn if Nuvigil (armodafini...
Location
University of Texas MD Anderson Cancer Center
Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib
PHASE3IPI-504-06 is a Phase 3, randomized, double-blind, placebo-controlled, mult...
Location
Multiple Locations